XML 20 R7.htm IDEA: XBRL DOCUMENT v3.8.0.1
CONSOLIDATED STATEMENT OF CASH FLOWS - USD ($)
$ in Millions
12 Months Ended
Oct. 31, 2017
Oct. 31, 2016
Oct. 31, 2015
Cash flows from operating activities:      
Net income $ 102 $ 335 $ 513
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization 225 134 99
Share-based compensation 56 49 55
Excess tax (benefit) deficiency from share-based plans (3) 5 (4)
Amortization of Debt Issuance Costs 9 0 0
Deferred tax expense (benefit) (47) 17 (163)
Excess and obsolete inventory related charges 16 17 28
Gain on sale of land (8) (10) 0
Asset impairment 7 0 0
Pension curtailment and settlement gains (69) 0 0
Other non-cash expenses (income), net 10 4 14
Changes in assets and liabilities:      
Accounts receivable (11) (42) (20)
Inventory (4) (22) (25)
Accounts payable 15 (8) 18
Payment (to)/from Agilent, net 0 0 (28)
Employee compensation and benefits (1) 16 6
Increase (Decrease) in Deferred Revenue 90 15 (24)
Income taxes payable 3 (9) 2
Retirement and post-retirement benefits (15) (32) (44)
Other assets and liabilities (62) (53) (51)
Net cash provided by operating activities 313 416 376
Cash flows from investing activities:      
Purchases of property, plant and equipment (72) (91) (92)
Proceeds from the sale of property, plant and equipment 8 10 1
Acquisitions of businesses and intangible assets, net of cash acquired (1,702) (10) (574)
Purchase of investments (1) 0 (7)
Proceeds from the sale of investments 45 1 1
Net cash used in investing activities (1,722) (90) (671)
Cash flows from financing activities:      
Issuance of common stock under employee stock plans 51 43 26
Proceeds from Issuance of Common Stock 444 0 0
Payments for Repurchase of Common Stock 0 (62) 0
Proceeds from issuance of long-term debt 1,069 0 0
Debt issuance costs (16) 0 0
Proceeds from short-term borrowings 212 0 0
Repayment of debt and credit facility (323) (1) 0
Excess tax benefit (deficiency) from share-based plans 3 (5) 4
Return of capital to Agilent 0 0 (49)
Net cash provided by/(used in) financing activities 1,440 (25) (19)
Effect of exchange rate movements 4 (1) (13)
Net increase/(decrease) in cash and cash equivalents 35 300 (327)
Cash and cash equivalents at beginning of year 783 483 810
Cash and cash equivalents at end of year $ 818 $ 783 $ 483